Featured Research

from universities, journals, and other organizations

Hopkins Scientists Link Human Papillomavirus To Head And Neck Cancer

Date:
May 4, 2000
Source:
Johns Hopkins Medical Institutions
Summary:
Researchers at the Johns Hopkins School of Medicine and School of Hygiene and Public Health have found the sexually transmitted human papillomavirus (HPV) to be a likely cause of certain cancers of the head and neck and also an indicator of improved survival.

Researchers at the Johns Hopkins School of Medicine and School of Hygiene and Public Health have found the sexually transmitted human papillomavirus (HPV) to be a likely cause of certain cancers of the head and neck and also an indicator of improved survival. Their findings are reported in the May 3, 2000, issue of the Journal of the National Cancer Institute.

Related Articles


The investigators studied tumors of 253 patients, ages 17 to 91, with newly diagnosed or recurring squamous cell head and neck cancer. HPV was detected in 62, or 25 percent, of the tumors and, of the HPV-positive tumors, 90 percent contained a high-risk, tumor-promoting form of the virus known as HPV-16. Somewhat unexpectedly, perhaps, those with HPV-positive tumors were 60 percent less likely to die from their head and neck cancer than those with HPV-negative tumors, according to the researchers. The data provide strong evidence that HPVs may be the cause of a defined subset of head and neck cancers, particularly those of the oropharynx (tonsils and throat), and this association with HPV infection also is linked to a markedly improved prognosis. While they currently cannot explain the improved survival, follow-up of participants revealed that the average survival of patients with HPV-positive tumors was 91 months or more but 76 months among patients with HPV-negative tumors. Other factors contributing to poor prognosis included advanced disease, age, and heavy alcohol consumption.

"These data suggest that HPV-positive head and neck cancers may comprise a distinct molecular, clinical, and pathologic disease very different from other types of the disease," says the Oncology Center's Maura L. Gillison, M.D., lead author of the study.

Squamous cell head and neck cancer is a disease largely attributable to environmental exposures-primarily tobacco and alcohol use. Fifteen to 20 percent of these cancers, however, occur in non-smokers and non-drinkers. "In this study, those with HPV-positive tumors in the oropharynx were light- or non-drinkers and non-smokers. We believe that HPV infection of the upper airway may be the cause of tumor development in this group of people," says Gillison. The researchers believe HPV causes the formation of head and neck cancers by producing two HPV-associated oncoproteins or growth-promoting proteins known as E6 and E7, which, in turn, inactivate the p53 and Rb tumor suppressor genes. They are planning a clinical trial of a cancer vaccine used for HPV-associated cervical cancers in these HPV-positive head and neck cancers. The vaccine would be given prior to standard therapy with surgery and/or radiation therapy.

"Although HPV DNA has been detected in head and neck cancers for sometime, its role in cancer development and the means by which HPV is transmitted to the upper airway has remained unclear," says one of the study's senior investigators, David Sidransky, M.D., professor of otolaryngology and oncology.

Although HPV presence in head and neck cancers has not yet been convincingly tied to specific sexual practices, HPV infection in head and neck cancer patients has been linked to the number of sexual partners in other studies, according to the researchers. "All of the evidence points to viral presence preceding disease progression," says Keerti V. Shah, M.D., Dr.P.H., professor of molecular microbiology and immunology.

An estimated 31,000 people in the United States are diagnosed each year with cancer of the oral cavity and pharynx. An additional 8,500 die each year from the disease. HPV is a sexually transmitted virus most recognized for its association with cervical and other genital squamous cell cancers.

###

In addition to Gillison, Sidransky, and Shah, other participants in this research include Wayne M. Koch, M.D., Randolph B. Capone, M.D., Michael Spafford, M.D., William H.Westra, M.D., Li Wu, Marianna L. Zahurak, M.S., Richard W. Daniel, B.S., Michael Viglione, M.D., and David E. Symer, M.D., Ph.D. The study was funded by the National Institutes of Health and a Clinical Oncology Research Career Development Program grant.

Related Web site: The Johns Hopkins Oncology Center: http://www.hopkins.cancercenter.jhmi.edu


Story Source:

The above story is based on materials provided by Johns Hopkins Medical Institutions. Note: Materials may be edited for content and length.


Cite This Page:

Johns Hopkins Medical Institutions. "Hopkins Scientists Link Human Papillomavirus To Head And Neck Cancer." ScienceDaily. ScienceDaily, 4 May 2000. <www.sciencedaily.com/releases/2000/05/000503181213.htm>.
Johns Hopkins Medical Institutions. (2000, May 4). Hopkins Scientists Link Human Papillomavirus To Head And Neck Cancer. ScienceDaily. Retrieved October 31, 2014 from www.sciencedaily.com/releases/2000/05/000503181213.htm
Johns Hopkins Medical Institutions. "Hopkins Scientists Link Human Papillomavirus To Head And Neck Cancer." ScienceDaily. www.sciencedaily.com/releases/2000/05/000503181213.htm (accessed October 31, 2014).

Share This



More Health & Medicine News

Friday, October 31, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Melafind: Spotting Melanoma Without a Biopsy

Melafind: Spotting Melanoma Without a Biopsy

Ivanhoe (Oct. 31, 2014) The MelaFind device is a pain-free way to check suspicious moles for melanoma, without the need for a biopsy. Video provided by Ivanhoe
Powered by NewsLook.com
Battling Multiple Myeloma

Battling Multiple Myeloma

Ivanhoe (Oct. 31, 2014) The answer isn’t always found in new drugs – repurposing an ‘old’ drug that could mean better multiple myeloma treatment, and hope. Video provided by Ivanhoe
Powered by NewsLook.com
Chronic Inflammation and Prostate Cancer

Chronic Inflammation and Prostate Cancer

Ivanhoe (Oct. 31, 2014) New information that is linking chronic inflammation in the prostate and prostate cancer, which may help doctors and patients prevent cancer in the future. Video provided by Ivanhoe
Powered by NewsLook.com
Sickle Cell: Stopping Kids’ Silent Strokes

Sickle Cell: Stopping Kids’ Silent Strokes

Ivanhoe (Oct. 31, 2014) Blood transfusions are proving crucial to young sickle cell patients by helping prevent strokes, even when there is no outward sign of brain injury. Video provided by Ivanhoe
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins